A submission to the US Food and Drug Administration (FDA) requesting an Emergency Use Authorization (EUA) of a 10-µg booster dose of Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine for ...
Seniors who have already received a vaccine targeting the omicron BA.5 subvariant are now eligible to receive another dose four months after their last shot. People with weak immune systems can ...
Aiming to provide additional protection for Americans against the coronavirus over the upcoming flu season, the FDA authorized new versions of Pfizer and Moderna’s Covid-19 vaccines. WASHINGTON (CN) — ...
Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday. Pfizer plans to give the data to U.S. regulators later this week in a ...
March 26, 2024 – The FDA has approved a new antibody treatment to help prevent COVID-19 in those who are most at risk from the virus. In its announcement, the agency explained that the new ...
Last fall, U.S. health officials authorized new COVID-19 booster shots designed to target the original strain of the coronavirus and some of the Omicron subvariants that were circulating around ...
“This decision comes at a time when Covid-19 cases are once again climbing,” Bourla said The US Food and Drug Administration (FDA) approved the latest versions of COVID-19 vaccines developed ...
T he COVID vaccine may be linked to a small increase in stroke risk when given with a high-dose flu shot, primarily in ...
“You are not a horse,” read a tweet posted by the Food and Drug Administration on Aug. 21, 2021. A fairly unexceptionable observation, one would think. But there was more to the tweet than a ...
Opinions expressed by Forbes Contributors are their own. I am a writer, journalist, professor, systems modeler, computational and digital health expert, avocado-eater, and entrepreneur, not always ...
Opinions expressed by Forbes Contributors are their own. I’m a virologist interested in pathogenesis and health disparities. In the continuing effort to mitigate the effects of Covid-19, the U.S ...
Brazilian drug regulator Anvisa on Monday (Jul. 24) gave its full approval for the bivalent Comirnaty COVID-19 vaccine by Pfizer. The jab is recommended for the prevention of COVID-19 and may now ...